South Korea’s Eubiologics Co. Ltd. said it gained the World Health Organization’s (WHO) prequalification designation on April 16 for its simplified oral cholera vaccine, approved as Euvichol-S. Read this story
South Korea’s Eubiologics Co. Ltd. said it gained the World Health Organization’s (WHO) prequalification designation on April 16 for its simplified oral cholera vaccine, approved as Euvichol-S. Read this story
More from BioWorld MedTech | BioWorld Eubiologics Co. Ltd. World Health Organization Euvichol-S Euvichol-Plus Euvichol prequalification cholera oral vaccine BioWorld Asia Asia-Pacific Regulatory Vaccine Infection Gastrointestinal WHO Cholera vaccine EuBiologics Co International Vaccine Institute